drugset / Trial / NCT03026855

Autologous Platelet Rich Plasma (PRP) for the Treatment of Chronic Non-Healing Ulcers

NCT03026855

Phase 1 Completed 24 enrolled TotipotentRX Cell Therapy Pvt. Ltd.
NaSingle-groupOpen-labelSupportive care

Summary

The purpose of this study is to evaluate the safety and efficacy of autologous PRP injection in combination with topical application of PRP gel in treating chronic or non-healing ulcers on lower extremity using a rapid, intra-operative, point-of-care technology at the patient's bedside.

Timeline

Start
2014-06
Primary completion
2016-04
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified Subcutaneous

Indications